Global Eye Drops (Artificial Tear) Market Growth 2025-2031

Publication ID:

LPI04258923

Publication Date:

April 15, 2025

Pages:

124

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Eye Drops (Artificial Tear) market size is predicted to grow from US$ 3435 million in 2025 to US$ 4306 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
Lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations.
The artificial tears and lubricants market is driven by the increasing prevalence of dry eye syndrome and the growing awareness of the importance of ocular health. Artificial tears and lubricants are eye drops and ointments used to alleviate dryness and discomfort in the eyes caused by various factors, including aging, digital device use, and environmental conditions. The rise in the aging population and the prevalence of conditions like Sj枚gren"s syndrome contribute to market growth as artificial tears provide relief and improve ocular surface health. Moreover, advancements in formulation technology and the development of preservative-free and longer-lasting products have enhanced their efficacy and patient compliance. However, the market also faces challenges, including the need for proper diagnosis and patient education to ensure appropriate product selection and usage. Additionally, addressing competition from alternative dry eye treatments and maintaining affordable pricing can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and effective artificial tears and lubricants, collaborate with eye care professionals to promote their benefits, and address the challenges to meet the increasing demand for ocular health solutions.
publisher, Inc. (LPI) ' newest research report, the 鈥淓ye Drops (Artificial Tear) Industry Forecast鈥� looks at past sales and reviews total world Eye Drops (Artificial Tear) sales in 2024, providing a comprehensive analysis by region and market sector of projected Eye Drops (Artificial Tear) sales for 2025 through 2031. With Eye Drops (Artificial Tear) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eye Drops (Artificial Tear) industry.
This Insight Report provides a comprehensive analysis of the global Eye Drops (Artificial Tear) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Eye Drops (Artificial Tear) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Eye Drops (Artificial Tear) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eye Drops (Artificial Tear) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eye Drops (Artificial Tear).
This report presents a comprehensive overview, market shares, and growth opportunities of Eye Drops (Artificial Tear) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Allergy Eye Care
Standard Eye Care
Segmentation by Application:
Pharmacy
Internet
Grocery
Optical Chains
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Allergan
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Eye Drops (Artificial Tear) market?
What factors are driving Eye Drops (Artificial Tear) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Eye Drops (Artificial Tear) market opportunities vary by end market size?
How does Eye Drops (Artificial Tear) break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Eye Drops (Artificial Tear) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Eye Drops (Artificial Tear) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Eye Drops (Artificial Tear) by Country/Region, 2020, 2024 & 2031
2.2 Eye Drops (Artificial Tear) Segment by Type
2.2.1 Allergy Eye Care
2.2.2 Standard Eye Care
2.3 Eye Drops (Artificial Tear) Sales by Type
2.3.1 Global Eye Drops (Artificial Tear) Sales Market Share by Type (2020-2025)
2.3.2 Global Eye Drops (Artificial Tear) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Eye Drops (Artificial Tear) Sale Price by Type (2020-2025)
2.4 Eye Drops (Artificial Tear) Segment by Application
2.4.1 Pharmacy
2.4.2 Internet
2.4.3 Grocery
2.4.4 Optical Chains
2.5 Eye Drops (Artificial Tear) Sales by Application
2.5.1 Global Eye Drops (Artificial Tear) Sale Market Share by Application (2020-2025)
2.5.2 Global Eye Drops (Artificial Tear) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Eye Drops (Artificial Tear) Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Eye Drops (Artificial Tear) Breakdown Data by Company
3.1.1 Global Eye Drops (Artificial Tear) Annual Sales by Company (2020-2025)
3.1.2 Global Eye Drops (Artificial Tear) Sales Market Share by Company (2020-2025)
3.2 Global Eye Drops (Artificial Tear) Annual Revenue by Company (2020-2025)
3.2.1 Global Eye Drops (Artificial Tear) Revenue by Company (2020-2025)
3.2.2 Global Eye Drops (Artificial Tear) Revenue Market Share by Company (2020-2025)
3.3 Global Eye Drops (Artificial Tear) Sale Price by Company
3.4 Key Manufacturers Eye Drops (Artificial Tear) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Eye Drops (Artificial Tear) Product Location Distribution
3.4.2 Players Eye Drops (Artificial Tear) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Eye Drops (Artificial Tear) by Geographic Region
4.1 World Historic Eye Drops (Artificial Tear) Market Size by Geographic Region (2020-2025)
4.1.1 Global Eye Drops (Artificial Tear) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Eye Drops (Artificial Tear) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Eye Drops (Artificial Tear) Market Size by Country/Region (2020-2025)
4.2.1 Global Eye Drops (Artificial Tear) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Eye Drops (Artificial Tear) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Eye Drops (Artificial Tear) Sales Growth
4.4 APAC Eye Drops (Artificial Tear) Sales Growth
4.5 Europe Eye Drops (Artificial Tear) Sales Growth
4.6 Middle East & Africa Eye Drops (Artificial Tear) Sales Growth
5 Americas
5.1 Americas Eye Drops (Artificial Tear) Sales by Country
5.1.1 Americas Eye Drops (Artificial Tear) Sales by Country (2020-2025)
5.1.2 Americas Eye Drops (Artificial Tear) Revenue by Country (2020-2025)
5.2 Americas Eye Drops (Artificial Tear) Sales by Type (2020-2025)
5.3 Americas Eye Drops (Artificial Tear) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Eye Drops (Artificial Tear) Sales by Region
6.1.1 APAC Eye Drops (Artificial Tear) Sales by Region (2020-2025)
6.1.2 APAC Eye Drops (Artificial Tear) Revenue by Region (2020-2025)
6.2 APAC Eye Drops (Artificial Tear) Sales by Type (2020-2025)
6.3 APAC Eye Drops (Artificial Tear) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Eye Drops (Artificial Tear) by Country
7.1.1 Europe Eye Drops (Artificial Tear) Sales by Country (2020-2025)
7.1.2 Europe Eye Drops (Artificial Tear) Revenue by Country (2020-2025)
7.2 Europe Eye Drops (Artificial Tear) Sales by Type (2020-2025)
7.3 Europe Eye Drops (Artificial Tear) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Eye Drops (Artificial Tear) by Country
8.1.1 Middle East & Africa Eye Drops (Artificial Tear) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Eye Drops (Artificial Tear) Revenue by Country (2020-2025)
8.2 Middle East & Africa Eye Drops (Artificial Tear) Sales by Type (2020-2025)
8.3 Middle East & Africa Eye Drops (Artificial Tear) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Eye Drops (Artificial Tear)
10.3 Manufacturing Process Analysis of Eye Drops (Artificial Tear)
10.4 Industry Chain Structure of Eye Drops (Artificial Tear)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Eye Drops (Artificial Tear) Distributors
11.3 Eye Drops (Artificial Tear) Customer
12 World Forecast Review for Eye Drops (Artificial Tear) by Geographic Region
12.1 Global Eye Drops (Artificial Tear) Market Size Forecast by Region
12.1.1 Global Eye Drops (Artificial Tear) Forecast by Region (2026-2031)
12.1.2 Global Eye Drops (Artificial Tear) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Eye Drops (Artificial Tear) Forecast by Type (2026-2031)
12.7 Global Eye Drops (Artificial Tear) Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Allergan
13.1.1 Allergan Company Information
13.1.2 Allergan Eye Drops (Artificial Tear) Product Portfolios and Specifications
13.1.3 Allergan Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Allergan Main Business Overview
13.1.5 Allergan Latest Developments
13.2 Alcon
13.2.1 Alcon Company Information
13.2.2 Alcon Eye Drops (Artificial Tear) Product Portfolios and Specifications
13.2.3 Alcon Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Alcon Main Business Overview
13.2.5 Alcon Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Eye Drops (Artificial Tear) Product Portfolios and Specifications
13.3.3 Novartis Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Santen Pharma
13.4.1 Santen Pharma Company Information
13.4.2 Santen Pharma Eye Drops (Artificial Tear) Product Portfolios and Specifications
13.4.3 Santen Pharma Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Santen Pharma Main Business Overview
13.4.5 Santen Pharma Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Eye Drops (Artificial Tear) Product Portfolios and Specifications
13.5.3 Johnson & Johnson Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Bausch & Lomb
13.6.1 Bausch & Lomb Company Information
13.6.2 Bausch & Lomb Eye Drops (Artificial Tear) Product Portfolios and Specifications
13.6.3 Bausch & Lomb Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Bausch & Lomb Main Business Overview
13.6.5 Bausch & Lomb Latest Developments
13.7 Thea pharmaceuticals
13.7.1 Thea pharmaceuticals Company Information
13.7.2 Thea pharmaceuticals Eye Drops (Artificial Tear) Product Portfolios and Specifications
13.7.3 Thea pharmaceuticals Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Thea pharmaceuticals Main Business Overview
13.7.5 Thea pharmaceuticals Latest Developments
13.8 URSAPHARM
13.8.1 URSAPHARM Company Information
13.8.2 URSAPHARM Eye Drops (Artificial Tear) Product Portfolios and Specifications
13.8.3 URSAPHARM Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 URSAPHARM Main Business Overview
13.8.5 URSAPHARM Latest Developments
13.9 SIMILASAN
13.9.1 SIMILASAN Company Information
13.9.2 SIMILASAN Eye Drops (Artificial Tear) Product Portfolios and Specifications
13.9.3 SIMILASAN Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 SIMILASAN Main Business Overview
13.9.5 SIMILASAN Latest Developments
13.10 Akorn
13.10.1 Akorn Company Information
13.10.2 Akorn Eye Drops (Artificial Tear) Product Portfolios and Specifications
13.10.3 Akorn Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Akorn Main Business Overview
13.10.5 Akorn Latest Developments
13.11 United Laboratories
13.11.1 United Laboratories Company Information
13.11.2 United Laboratories Eye Drops (Artificial Tear) Product Portfolios and Specifications
13.11.3 United Laboratories Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 United Laboratories Main Business Overview
13.11.5 United Laboratories Latest Developments
13.12 Sun Pharmaceutical
13.12.1 Sun Pharmaceutical Company Information
13.12.2 Sun Pharmaceutical Eye Drops (Artificial Tear) Product Portfolios and Specifications
13.12.3 Sun Pharmaceutical Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Sun Pharmaceutical Main Business Overview
13.12.5 Sun Pharmaceutical Latest Developments
13.13 Jianfeng Group
13.13.1 Jianfeng Group Company Information
13.13.2 Jianfeng Group Eye Drops (Artificial Tear) Product Portfolios and Specifications
13.13.3 Jianfeng Group Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Jianfeng Group Main Business Overview
13.13.5 Jianfeng Group Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂